Actively Recruiting
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
Led by State University of New York at Buffalo · Updated on 2026-02-20
30
Participants Needed
2
Research Sites
267 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard treatment of cancer.
CONDITIONS
Official Title
A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically documented cancer and eligible for cytotoxic chemotherapy
- Life expectancy of at least 6 months
- Adults 18 years of age or older
- Adequate blood counts: WBC ≥ 2,500 cells/µL, ANC ≥ 1,000 cells/µL, Platelets ≥ 100,000 cells/µL, Hemoglobin ≥ 9.0 g/dL
- Adequate kidney and liver function: Creatinine ≤ 2.0 mg/dL, Total bilirubin ≤ 2 x upper limit of normal, AST ≤ 2.5 x upper limit of normal, ALT ≤ 2.5 x upper limit of normal
You will not qualify if you...
- Eastern Cooperative Oncology Group (ECOG) performance status 2 or higher
- Treatment with systemic corticosteroids or high dose calcitriol within 28 days prior to registration (inhaled, intranasal, and topical steroids allowed)
- Infection requiring parenteral antibiotics or fever above 100.5°F (38.1°C) within 1 week prior to registration
- Known allergy or contraindication to contrast dye needed for CT/MRI imaging
- Any condition or intervention that may prevent adherence to study requirements or compromise study goals, as judged by the Principal Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University at Buffalo / Great Lakes Cancer Care
Buffalo, New York, United States, 14203
Actively Recruiting
2
University at Buffalo / Great Lakes Cancer Care
Buffalo, New York, United States, 14206
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here